Precigen Inc (PGEN)
Healthcare
Biotechnology
6.50 $
-1.2%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
| Tick rows to compare them in a chart (up to 4) | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +32.1% | +209.6% | +22.7% | +70.4% | -3.4% | -10.8% | -15.4% | -36.4% | -31.0% | +14.4% | -40.0% | -30.1% | -3.8% | +7.8% | |
| – | -41.1% | +1,285.9% | -6.8% | +85.3% | -2.7% | -51.1% | +85.3% | -17.8% | -36.5% | +5.2% | -24.6% | -41.8% | +49.0% | +12.5% | |
| – | -47.0% | +375.9% | -44.5% | +394.4% | -53.9% | +8.8% | +50.9% | -36.0% | -21.3% | -29.7% | -86.7% | +56.0% | +289.5% | +2.4% | |
| – | -46.4% | +1,564.5% | -34.7% | +105.5% | -0.5% | -66.4% | +179.7% | -66.3% | +33.4% | +8.5% | -48.5% | +12.3% | +55.8% | -0.1% | |
| – | -47.3% | +940.6% | +297.8% | +78.7% | -18.8% | -6.2% | -33.3% | -1.3% | -22.1% | -90.3% | +597.2% | -88.6% | -26.2% | +275.1% | |
| – | – | – | – | +3.0% | -20.4% | -3.1% | +4.7% | -24.9% | -29.4% | -97.1% | -12.0% | -100.0% | -100.0% | – | |
| – | – | – | – | +12.5% | +51.3% | +74.2% | +14.4% | -52.7% | -42.7% | +29.5% | -83.8% | – | – | – | |
| – | – | – | +631.1% | +63.4% | -4.8% | -2.5% | -2.4% | -57.4% | -14.7% | -30.9% | -1.7% | -27.9% | -28.1% | -20.4% | |
| – | -9.3% | +42.2% | +57.2% | +275.4% | -8.9% | +3.2% | -44.5% | -47.1% | -4.3% | -20.0% | -15.0% | -8.4% | -89.1% | -28.6% | |
| – | +40.8% | -81.4% | +89.5% | +66.0% | +37.0% | -20.9% | +12.4% | +13.8% | -35.6% | +2.1% | -64.5% | -63.7% | +228.0% | +27.1% | |
| – | -5.0% | +18.6% | +139.5% | +59.9% | +24.6% | -15.3% | -23.2% | +99.7% | -65.7% | -17.8% | +127.0% | -70.8% | -6.4% | +73.4% | |
| – | -31.0% | -38.8% | +13,060.0% | -62.2% | -19.1% | -39.1% | +28.6% | +3,733.4% | -91.7% | -52.1% | +2,974.6% | -97.3% | -20.5% | +18.8% | |
| – | -79.6% | +67.2% | +492.9% | -20.7% | +70.7% | +2.6% | +37.6% | -53.8% | -16.8% | -32.3% | +30.7% | -57.6% | +104.6% | +239.4% | |
| – | – | – | – | -12.6% | -0.5% | -0.4% | +2,703.4% | -11.8% | -7.9% | +6.5% | – | – | – | – | |
| – | – | – | +4.9% | +80.4% | -19.3% | -4.7% | -32.0% | -80.2% | -6.3% | +59.8% | +17.6% | -6.1% | -67.5% | -45.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.3% | +640.0% | +142.2% | +12.0% | +6.2% | +1.7% | +7.9% | +19.0% | +8.4% | +18.4% | +1.3% | +22.0% | +9.5% | +13.8% |
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.